norstella-logo-white
News

NorstellaLinQ in the news

Since introducing NorstellaLinQ, biopharma’s first fully integrated data asset combining RWD and our wealth of proprietary information, we have been busily meeting with customers to explain how it can support their workflows. It is not only our pharma partners that have taken notice, but the trade media has also wanted to learn more. Suzanne Caruso, General Manager for Clinical & Regulatory at Norstella, met with reporters from STAT and Precision Medicine Online to explain.

In STAT, we were profiled among six leading companies using AI to streamline clinical trials. The way we are organizing our data and feeding it into AI models is powering a range of applications that reduce friction within the clinical trial process. Citeline has already launched its own investigator selection and protocol design recommendation engines. Similarly, pharma companies can harness NorstellaLinQ as the data foundation for their own AI applications. As Suzanne described, “there is truly a lot of inefficiency in the system because there’s so much manual work. Can we help the experts get to the last mile faster?”

Our discussion with Precision Medicine Online focused on the need to expedite patient screening and enrollment within clinical trials. With NorstellaLinQ, sponsors and sites can scan anonymized RWD within an individual investigator’s remit to identify patients who might qualify for a study. “Investigators do not have a ton of time and staff to be hunting through electronic medical record systems every single day for hours to find out whether someone has presented within the hospital that might qualify for a study,” explained Suzanne. This can be done in a highly sophisticated manner, such as mirroring the complex treatment pathways and eligibility criteria for targeted oncology drugs. By creating ontologies that organize unstructured medical records, NorstellaLinQ is designed for user simplicity. “Show me every patient with this biomarker” is the ultimate expression of this.

You can find the full articles at the links below.

STAT: These 6 companies are using AI to streamline clinical trials for pharma

Precision Medicine Online: AI Offers Potential to Streamline Patient Screening for Precision Medicine Clinical Trials


Learn more about NorstellaLinQ today.

Work with us

Join our mission

We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.

Work with us
work-with-us-img
get-in-touch-img

Get in Touch

Let's connect

Have questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?

We want to hear from you